The Line Between Nuisance and Severe Eczema

Is there a number that makes eczema severe?

Not one that settles it. The instrument used in research is the EASI, the Eczema Area and Severity Index, introduced by Hanifin and the EASI Evaluator Group as a clinician-rated measure of both the severity and the extent of atopic dermatitis 1Ref 1Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M (2001).The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group.That the EASI originates with Hanifin and the EASI Evaluator Group as a clinician-rated measure of the severity and extent of atopic dermatitis, and its reliability evidence: 15 trained dermatologist evaluators scoring 20 patients on two consecutive days, with intra-evaluator reliability in the fair-to-good range, consistent inter-evaluator assessment across both days, and the authors' judgement that it can be learned quickly and used reliably.. It yields a single figure, higher meaning worse. What it does not yield is a bright line where nuisance ends and severe begins.

Part of the reason is that eczema will not hold still. It is a chronic inflammatory, itchy skin disease that runs in flares and remissions 2Ref 2National Institute of Arthritis and Musculoskeletal and Skin Diseases (2024).Atopic Dermatitis (Eczema).The definitional statement that atopic dermatitis is a chronic inflammatory, itchy skin disease that follows a course of flares and remissions., so any score is a reading taken on one day of something that has better and worse fortnights. Ask on a Tuesday and the answer differs from Friday's. The bands people quote — mild, moderate, severe — were layered onto the scale by later consensus work rather than written into the instrument at its origin.

What the EASI actually scores

Two dimensions, multiplied together, region by region. For each of four body areas — head and neck, trunk, upper limbs, lower limbs — a clinician grades how the skin looks and how much of that area is involved. The signs graded are redness, thickness or swelling, scratch marks, and lichenification: the leathery thickening that comes of years of rubbing the same patch. Extent and severity are both built in by design 1Ref 1Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M (2001).The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group.That the EASI originates with Hanifin and the EASI Evaluator Group as a clinician-rated measure of the severity and extent of atopic dermatitis, and its reliability evidence: 15 trained dermatologist evaluators scoring 20 patients on two consecutive days, with intra-evaluator reliability in the fair-to-good range, consistent inter-evaluator assessment across both days, and the authors' judgement that it can be learned quickly and used reliably..

Region scores are weighted by size and added together; in the scoring convention in general use, the total runs from 0 to 72. Almost nobody reaches the ceiling, and the absolute figure matters far less than what it does over time. The value of a severity score is that the same clinician, using the same instrument, can set your skin this month beside your skin three months ago.

How reliable is the score?

Reliable enough to track one person over time, not precise enough to compare across clinics. Its reliability study had 15 trained dermatologist evaluators score 20 patients with atopic dermatitis on two consecutive days. Intra-evaluator reliability came out in the fair-to-good range, assessment between evaluators was consistent across both days, and the authors judged that the instrument can be learned quickly and used reliably in assessing the severity and extent of the disease 1Ref 1Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M (2001).The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group.That the EASI originates with Hanifin and the EASI Evaluator Group as a clinician-rated measure of the severity and extent of atopic dermatitis, and its reliability evidence: 15 trained dermatologist evaluators scoring 20 patients on two consecutive days, with intra-evaluator reliability in the fair-to-good range, consistent inter-evaluator assessment across both days, and the authors' judgement that it can be learned quickly and used reliably..

That phrasing is honest and unusual, and worth reading closely. Fair-to-good is not excellent. It means two careful dermatologists may place the same skin a few points apart, and the same dermatologist may not land on precisely the same number two mornings running. So a shift of two or three points between visits is noise. A shift large enough to change what the skin is visibly doing, across more than one region, is signal.

The definition that actually decides treatment

In practice, severity is defined by what it takes to hold the disease down. The AAD's guidance for adults lays out the topical tier: moisturisers and bathing practices, topical corticosteroids, topical calcineurin inhibitors such as tacrolimus and pimecrolimus, crisaborole, and a topical JAK inhibitor 3Ref 3Sidbury R, Alikhan A, Bercovitch L, et al. (2023).Guidelines of care for the management of atopic dermatitis in adults with topical therapies.That the AAD's topical-therapy guidance for adults comprises moisturisers and bathing practices, topical corticosteroids, topical calcineurin inhibitors (tacrolimus, pimecrolimus), crisaborole and a topical JAK inhibitor — the first tier of eczema management.. Those are the first several rungs of the adult eczema ladder, and most eczema is held somewhere on them.

Moderate-to-severe is the name for what those rungs no longer hold. It is the tier at which the AAD's separate guidance for phototherapy and systemic therapy applies — dupilumab and other biologics, JAK inhibitors, and the older systemic immunosuppressants 4Ref 4Sidbury R, Davis DM, Alikhan A, et al. (2024).Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies.That phototherapy and systemic therapy — dupilumab and other biologics, JAK inhibitors, and traditional systemic immunosuppressants — form the tier of AAD guidance that applies to moderate-to-severe atopic dermatitis in adults.. That is why the phrase turns up on prior-authorisation forms: it marks the boundary between two guideline documents, not a description of how wretched you feel. Steroid-resistant eczema is the everyday name for arriving there, and eczema systemic options are what sits on the far side.

Severity you cannot see on the skin

Sleep is the first casualty and the least documented. Itch is worst at night, so in the room severity is often really being measured by how many nights a week this wakes someone — a number no area-based score contains. The AAP's clinical report on skin-directed management of childhood eczema explicitly flags attention to mental-health comorbidity alongside the physical treatment 5Ref 5Schoch JJ, Anderson KR, Jones AE, Tollefson MM (2025).Atopic Dermatitis: Update on Skin-Directed Management: Clinical Report.That the AAP clinical report frames pediatric management as a triad of maintenance skin care (bathing plus moisturisers), topical anti-inflammatory therapy and trigger avoidance, with escalation to biologics or JAK inhibitors for severe disease, and that it directs attention to mental-health comorbidity., which is a recognition in guideline language that burden and body-surface percentage come apart.

Eczema also sits inside a wider picture: immune dysregulation and a compromised skin barrier, with an association to the atopic march — food allergy, asthma and allergic rhinitis appearing over time 6Ref 6National Institute of Allergy and Infectious Diseases (2024).Eczema (Atopic Dermatitis).That atopic dermatitis involves immune dysregulation and skin-barrier dysfunction and is associated with the atopic march — food allergy, asthma and allergic rhinitis.. None of that is graded by looking at a patch of skin, and all of it belongs in an honest answer to how severe this is.

Children are graded from a different starting point

The framework for children begins with maintenance rather than rescue. The AAP describes a triad — bathing plus moisturisers as ongoing skin care, topical anti-inflammatory treatment with corticosteroids or calcineurin inhibitors, and trigger avoidance — with escalation to biologics or JAK inhibitors held for severe disease 5Ref 5Schoch JJ, Anderson KR, Jones AE, Tollefson MM (2025).Atopic Dermatitis: Update on Skin-Directed Management: Clinical Report.That the AAP clinical report frames pediatric management as a triad of maintenance skin care (bathing plus moisturisers), topical anti-inflammatory therapy and trigger avoidance, with escalation to biologics or JAK inhibitors for severe disease, and that it directs attention to mental-health comorbidity.. Severity in a child is read against how well that base is actually running.

The distinction is practical. A child flaring because the maintenance routine has quietly lapsed over a busy month is a different case from a child breaking through a routine that is genuinely being kept, even when a single-day score would look identical. Separating those two takes up a fair part of the appointment, which is why detailed questions about how much cream is used, and how often, are not scepticism about the answer.

Where an area-based score under-reads the problem

On hands, feet, and small patches that do outsized damage. The palms and soles are a tiny fraction of body surface and an enormous fraction of daily function. Dyshidrotic eczema treatment exists as its own topic largely for that reason: deep itchy blisters along the sides of the fingers can stop someone holding a pen, a steering wheel or a baby, while adding almost nothing to a percentage-of-body-covered figure.

Nummular eczema treatment poses the same problem from another direction — scattered coin-shaped plaques that are stubborn, intensely itchy and slow to clear while covering very little ground. The same tension runs through psoriasis severity, where a small area in the wrong place is not a small problem either. If the worst of it is somewhere small and functionally important, that has to be said out loud at the appointment, because the score will not say it.

What to bring so the grading comes out honest

The examination sees one day of this. Everything else has to be carried in, and a short written list beats recall, because appointments have a way of compressing a bad three months into "it's been up and down." What tends to change how severity is recorded:

• Dated photographs of a genuinely bad flare. Skin has a habit of behaving on the morning of the visit.
• Nights woken by itch in the past week or two, as an actual count.
• Days of work, school or activity lost, and anything quietly given up — swimming, short sleeves, staying over at a friend's.
• What has been tried: which treatment, for how long, over how much of the body, and whether it was continued until the skin cleared or stopped as soon as it improved.
• Which sites are involved now — hands, face, eyelids, folds, feet.
• Skin infections, courses of antibiotics, and any courses of oral steroids.

The last item matters more than it looks. Repeated infected flares and repeated rescue courses are themselves a severity statement, and they are the details most often missing from a note that then reads far milder than the year actually was.